Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 2
2021 7
2022 6
2023 9
2024 11
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Solanum melongena L. Extract Promotes Intestinal Tight Junction Re-Assembly via SIRT-1-Dependent Mechanisms.
Sukmak P, Kulworasreth P, Treveeravoot S, Arinno A, Anuwongworavet S, Wachiradejkul W, Kulworasreth P, Teansuk N, Thongnak L, Amonlerdpison D, Inchai J, Jakrachai C, Akrimajirachoote N, Aonbangkhen C, Muanprasat C, Poolsri W, Vaddhanaphuti CS, Pongkorpsakol P. Sukmak P, et al. Mol Nutr Food Res. 2024 Aug;68(16):e2400230. doi: 10.1002/mnfr.202400230. Epub 2024 Jul 31. Mol Nutr Food Res. 2024. PMID: 39086054
Safety and Immunogenicity of the BBIBP-CorV Vaccine in Adolescents Aged 12 to 17 Years in the Thai Population: An Immunobridging Study.
Tawinprai K, Siripongboonsitti T, Porntharukchareon T, Vanichsetakul P, Thonginnetra S, Niemsorn K, Promsena P, Tandhansakul M, Kasemlawan N, Ruangkijpaisal N, Banomyong N, Phattraprayoon N, Ungtrakul T, Wittayasak K, Thonwirak N, Soonklang K, Sornsamdang G, Mahanonda N. Tawinprai K, et al. Vaccines (Basel). 2022 May 19;10(5):807. doi: 10.3390/vaccines10050807. Vaccines (Basel). 2022. PMID: 35632562 Free PMC article.
Efficacy of combined COVID-19 convalescent plasma with oral RNA-dependent RNA polymerase inhibitor treatment versus neutralizing monoclonal antibody therapy in COVID-19 outpatients: a multi-center, non-inferiority, open-label randomized controlled trial (PlasMab).
Siripongboonsitti T, Nontawong N, Tawinprai K, Suptawiwat O, Soonklang K, Poovorawan Y, Mahanonda N. Siripongboonsitti T, et al. Microbiol Spectr. 2023 Dec 12;11(6):e0325723. doi: 10.1128/spectrum.03257-23. Epub 2023 Nov 17. Microbiol Spectr. 2023. PMID: 37975699 Free PMC article. Clinical Trial.
32 results